References
- Simpson J A. Myasthenia gravis: a new hypothesis. Scot med J 1960; 5: 419–436
- Thorlacius S, Aarli J A, Riise T, Matre R, Johnsen H J. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Ada neurol Scand 1989; 80: 290–295
- Aarli J A, Milde E J, Thunold S. Arthritis in myasthenia gravis. J Neurol Neurosurg Psychiat 1975; 38: 1048–1055
- Oosterhuis H JGH. Myasthenia Gravis. Clinical Neurology and Neurosurgery Monographs, 5, Churchill Livingstone, New York 1984; 156–158
- Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1982; 25: 1271–1277
- Bennett P H, Burch T A. The New York Symposium on population studies in the rheumatologic diseases. Bull Rheum Dis 1967; 17: 453–458
- Nerup J, Lernmark A. Autoimmunity in insulin‐dependent diabetes mellitus. Am J Med 1981; 70: 135–141
- Lefvert A K, Bergstrom K, Matell G, Osterman P O, Pirskanen R. Determination of acetylcholine receptor antibodies in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiat 1978; 41: 394–403
- Aarli J A, Lefvert A K, Tonder O. Thymoma‐specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination. J Neuroimmunol 1981; 1: 421–427
- Aarli J A, Stefansson K, Marton L SG, Wollman R L. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin exp Immunol 1990; 82: 284–288
- Gilhus N E, Matre R, Aarli J A, Hofstad H. Thunold S. Thymic lymphoepitheliomas and skeletal muscle expressing common antigen(s). Acta Neurol Scand 1986; 73: 428–433
- Otto H F. Berlin Heidelberg. Springer Verlag, Berlin Heidelberg 1984
- Klein J J, Gottlieb A J, Mones R J, Appel S K, Osserman K E. Thymoma and polymyositis; onset of myasthenia gravis after thymectomy, report of 2 cases. Arch int med 1964; 113: 142–152
- Weiller P ‐J, Durand J M, Prince‐Zuchelli M A, Cros D, Puget J, Pelissier J F, Mongin M. L'association polymyosite myastheni, thymome: un cas et revue de la litterature. Ann Med Interne 1984; 135: 299–304
- Compston D AS, Vincent A, Newsom‐Davis J, Batchelor J R. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579–601
- Gilhus N E, Matre R, Aarli J A. The immunology of thymoma in myasthenia gravis and other neurological diseases. Clinical N'euroimmunology, J A Aarli, W MH Behan, P O Behan. Blackwell, Oxford, London, Edinburgh 1987; 259–274
- Kaakinen A, Pirskanen R, Tiilikainen A. LD‐antigens associated with HL.‐A8 and myasthenia gravis. Tissue Antigens 1975; 6: 175–182
- Möller E, Hammarstrom L, Smith C IE, Matell G. HL.‐A8 and LD‐8a in patients with myasthenia gravis. Tissue Antigens 1976; 7: 39–44
- Carlsson B, Wallin J, Pirskanen R, Matell G, Smith C IE. Different HLA DR.‐DQ associations in subgroups of idiopathic myasthenia gravis. Immunogenetics 1990; 31: 285–290
- Tiwari J, Terasaki P I. HLA and Disease Associations. Springer Verlag, New York 1985
- Spurkland A, Gilhus N E, Ronningen K, Aarli J A, Vartdal F. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations. Tissue Antigens 1991; 37: 90–93